Veru (VERU) Earnings Date & Reports

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases... Show more

Industry: #Household Or Personal Care

Get AI intraday signals

A.I. Advisor

published Earnings

VERU is expected to report earnings to rise 8.33% to -32 cents per share on November 26

Q3'26

Est.

$-0.32

Q2'26

Beat

by $0.01

Q1'26

Missed

by $0.07

Q4'25

Missed

by $0.20

Q3'25

Beat

by $0.15

The last earnings report on August 10 showed earnings per share of -30 cents, beating the estimate of -31 cents. With 90.95K shares outstanding, the current market capitalization sits at 45.01M.

View a ticker or compare two or three

VERU

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days